| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/30/2007 | CN1969825A Sustained release agent containing fluorouracil and synergist thereof |
| 05/30/2007 | CN1969824A Anticancer sustained release agent containing fluorouracil and synergist thereof |
| 05/30/2007 | CN1969823A Sustained release agent containing fluorouracil and synergist thereof |
| 05/30/2007 | CN1969822A Red sage root salvianolic acid A injection formulation for treating cardiovascular diseases and preparation process thereof |
| 05/30/2007 | CN1969821A Anticancer medicament and synergist simultaneously carrying anticancer sustained release agent |
| 05/30/2007 | CN1969820A Anticancer pharmaceutical composition |
| 05/30/2007 | CN1969819A Anticancer pharmaceutical composition |
| 05/30/2007 | CN1969818A Anticancer sustained release injection containing epothilone derivatives |
| 05/30/2007 | CN1969817A Anticancer composition |
| 05/30/2007 | CN1969816A Anticancer sustained release agent containing epothilone |
| 05/30/2007 | CN1969815A Sustained release agent of curcumin and preparation method thereof |
| 05/30/2007 | CN1969814A Nasal administered preparation of melatonin |
| 05/30/2007 | CN1969683A Selenium and zinc enriched health food and preparation process thereof |
| 05/30/2007 | CN1969681A Buccal tablet prepared by fruits and royal jelly and production process thereof |
| 05/30/2007 | CN1318569C Method for preparing compound tea of ganoderma lucidum mycelium |
| 05/30/2007 | CN1318446C Transferrin receptor protein of Moraxella |
| 05/30/2007 | CN1318093C Injections for eye tissue containing drug bound to polyethylene glycol |
| 05/30/2007 | CN1318090C Medicine composition for improving stability of human urine kininogenase |
| 05/30/2007 | CN1318088C Oral cavity plastering sheet of interferon and its preparation method |
| 05/30/2007 | CN1318085C Ossotide injection and preparation method thereof |
| 05/30/2007 | CN1318083C Chinese patent medicine for preventing and treating apoplexia disease, and its production method and use |
| 05/30/2007 | CN1318082C Medicinal composition for treating chronic prostatitis and its preparation method and use |
| 05/30/2007 | CN1318077C Antivirus Chinese medicine compound preparation and its preparation method and use |
| 05/30/2007 | CN1318076C Bone numbness releasing medicine |
| 05/30/2007 | CN1318074C Medicine for treating child spasm syndrome and its preparation method |
| 05/30/2007 | CN1318068C Tonic liquid and preparing process thereof |
| 05/30/2007 | CN1318066C Medicine for treating dysmenorrhes and preparation thereof |
| 05/30/2007 | CN1318063C Inflammation-resisting itch-stopping lotion and its preparation method |
| 05/30/2007 | CN1318062C Composition containing extracts of pagodatree fruits, grape seeds and peel and preparation method thereof |
| 05/30/2007 | CN1318060C Preparation process of Chinese medicine soft capsule |
| 05/30/2007 | CN1318053C Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method |
| 05/30/2007 | CN1318051C Compound medicine with function of relaxing the bowels, and its preparation method |
| 05/30/2007 | CN1318047C Medicine for preventing and curing cardio cerebral vascular diseases and its preparing method |
| 05/30/2007 | CN1318043C Bupleurum oily emulsion injection liquid and its production method |
| 05/30/2007 | CN1318042C Application of barbat skullcap in preparing medication for treating diabetes |
| 05/30/2007 | CN1318039C Preparation method for instant agent of donkey-hide gelatin |
| 05/30/2007 | CN1318038C Medicine for treating recurrent psoriasis and its preparing process |
| 05/30/2007 | CN1318032C Ethinyl estradiol gas permeable absorbing paste |
| 05/30/2007 | CN1318030C Methods and compositions useful in enhancing oxygen delivery to cells |
| 05/30/2007 | CN1318028C Slow-releasing micro-balls of demethyl cantharidine, and its preparation method |
| 05/30/2007 | CN1318026C Solid pharmaceutical formulations comprising modafinil |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/30/2007 | CN1318022C Colored hard capsules |
| 05/30/2007 | CN1318021C Rapidly disintegrating table and process for manufacture thereof |
| 05/30/2007 | CN1318020C Blood nourishing, brain refreshing orally disintegrating tablet and its preparation process |
| 05/30/2007 | CN1318019C Solid dispersion comprising two different polymer matrixes |
| 05/30/2007 | CN1318014C Aerosol composition comprising silicate particles and surfactants |
| 05/29/2007 | US7223887 Multivalent cationic lipids and methods of using same in the production of lipid particles |
| 05/29/2007 | US7223857 Chain-shortened polynucleotide and method for preparation thereof |
| 05/29/2007 | US7223797 New salts such as meldonium dihydrogen phosphate, meldonium hydrogen fumarate or meldonium orotate; nonhygroscopic and/or increased thermal stability and/or lasting action |
| 05/29/2007 | US7223770 Tocopherol-modified therapeutic drug compounds |
| 05/29/2007 | US7223748 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223571 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 05/29/2007 | US7223570 Such as cyclo-glucopyranosyl derivatives via glucanotransferases, galactosidases, hydrolases, and glycosidases; for use in foods, cosmetics |
| 05/29/2007 | US7223561 Culturing yeast transformed with albumin-encoding nucleotide sequence in a fermentation medium; gene expression, separation, conditioning, adding sodium octanoate; cationic exchange chromatography, elution, ultrafiltration, sterilization, diafiltration, filling vessel |
| 05/29/2007 | US7223440 Residual solvent extraction method and microparticles produced thereby |
| 05/29/2007 | US7223422 Intraarticularly injecting a fluid in the joint space of an animal; the replacement fluid is synovial fluid that has been harvested from other animals and processed to remove impurities, cellular and pathogenic components, then lyophilized, packaged and reconstituted |
| 05/29/2007 | US7223421 Teste masked pharmaceutical particles |
| 05/29/2007 | US7223420 Powder mixture for resorbable calcium phosphate biocements |
| 05/29/2007 | US7223419 Stabilizing a high concentrate drug content in water, by dissolving the drug and a polyetheramide copolymer in solvent, forming water in oil emulsion, volatilizing, desolventizing, supersonic treatment and ultrafiltration |
| 05/29/2007 | US7223418 For percutaneous drug administration; does not irritate skin |
| 05/29/2007 | US7223413 Composition of a potassium channel opener, a potassium channel agonist and an adenosine receptor agonist; heart can be better protected during arrest and recovery by using the potassium channel opener adenosine and the local anaesthetic lignocaine |
| 05/29/2007 | US7223387 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| 05/29/2007 | US7223386 comprising silicone matrix, a hydrophilic carrier, and at least one active agent comprising proteins, particularly enzymes such as hydrolases and glucose oxidase for enzymatic debridement, clotting formation and clot removal and wound healing |
| 05/29/2007 | US7223381 Pressurised metered dose inhalers (MDI) |
| 05/29/2007 | CA2498415C Solid formulations comprising an indolinone compound |
| 05/29/2007 | CA2340052C Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 05/29/2007 | CA2338324C Stabilized carvedilol injection solution |
| 05/29/2007 | CA2336732C Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 05/29/2007 | CA2336711C Blister containing a transdermal therapeutic system and a single dose form of administration |
| 05/29/2007 | CA2333375C Sublingual buccal effervescent |
| 05/29/2007 | CA2313504C Folic acid in solid dosage forms |
| 05/29/2007 | CA2283852C Method and composition for coating wound or protecting animal skin |
| 05/29/2007 | CA2275420C Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 05/29/2007 | CA2268156C Bioceramic compositions |
| 05/29/2007 | CA2258679C Solid solution of an antifungal agent with enhanced bioavailability |
| 05/29/2007 | CA2251297C Oral preparations comprising s-(3-hydroxypropyl)-l-cysteine |
| 05/29/2007 | CA2247467C Use of piperine as a bioavailability enhancer |
| 05/29/2007 | CA2236428C Wettable powder compositions of ionophore antibiotics |
| 05/29/2007 | CA2213989C External preparation for topical administration |
| 05/29/2007 | CA2208754C Bioabsorbable oxidized cellulose composite material for prevention of postsurgical adhesions |
| 05/29/2007 | CA2173317C Pharmaceutically acceptable polymeric tissue coating |
| 05/29/2007 | CA2090612C Method of reversing local anesthesia and reagent system therefor |
| 05/24/2007 | WO2007059515A2 Compositions of lipoxygenase inhibitors |
| 05/24/2007 | WO2007059491A2 Novel hydrogels and uses thereof |
| 05/24/2007 | WO2007059422A2 Pharmaceutical formulations containing 5-cyclopropyl-2(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and method of making same |
| 05/24/2007 | WO2007059390A1 Injectable formulation capable of forming a drug-releasing device |
| 05/24/2007 | WO2007059171A2 Electrostatically controlled hydrogels |
| 05/24/2007 | WO2007058935A2 Ophthalmic composition for dry eye therapy |
| 05/24/2007 | WO2007058800A2 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 05/24/2007 | WO2007058664A1 Atorvastatin formulation |
| 05/24/2007 | WO2007058660A1 Segmented pharmaceutical dosage forms |
| 05/24/2007 | WO2007058645A1 Tablets comprising a core and a medicament-containing coating for buccal release |
| 05/24/2007 | WO2007058644A1 Methods of producing coated products including active agent and products regarding same |
| 05/24/2007 | WO2007058634A1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 05/24/2007 | WO2007058593A1 Quetiapine in a controlled release formulation |
| 05/24/2007 | WO2007058462A1 Method for preparing sustained-release microparticles comprising sucrose acetate isobutyrate |
| 05/24/2007 | WO2007058397A1 A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same |
| 05/24/2007 | WO2007058190A1 Controlled drug release composition and drug releasing medical device |